Rufinamide
Links shared publicly online about this topic
ingentaconnect Rufinamide: Vomiting, loss of appetite and exacerbation of partia...
ingentaconnect.com — “ingentaconnect Rufinamide: Vomiting, loss of appetite and exacerbation of partia...” View full resource at ingentaconnect.com
Most Recently Shared on October 28, 2011 at 11:51 am By:
Rufinamide: Vomiting, loss of appetite and exacerbation of partial epilepsy in children: 3 case reports: (Source... http://t.co/E7LcOkbG
BANZEL ORAL SUSPENSION (Rufinamide) drug information from MPR
empr.com — “BANZEL ORAL SUSPENSION (Rufinamide) drug information for Seizure disorders from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on June 21, 2011 at 4:14 am By:
MPR News: BANZEL ORAL SUSPENSION: Monograph added. http://bit.ly/kTUIkv
Epilepsy: Adjunctive Rufinamide Reduces Refractory Partial-Onset Seizures
medicalnewstoday.com — “Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial” View full resource at medicalnewstoday.com
Most Recently Shared on October 4, 2010 at 3:05 pm By:
Epilepsy: Adjunctive Rufinamide Reduces Refractory Partial-Onset Seizures http://mnt.to/3KJ7 #epilepsy
FDA Accepts BANZEL(R) (Rufinamide) Oral Suspension NDA For Review
medicalnewstoday.com — “Eisai Inc. (Headquarters: Woodcliff Lake, NJ; President and CEO: Lonnel Coats), a U.S. subsidiary of Eisai Co., Ltd. (Headquarters: Tokyo; President and CEO: Haruo Naito) announced that the U.S.” View full resource at medicalnewstoday.com
Most Recently Shared on July 21, 2010 at 12:14 pm By:
FDA Accepts BANZEL(R) (Rufinamide) Oral Suspension NDA For Review http://mnt.to/3GmX #epilepsy
Neurology Medical News about Anticonvulsants Vigabatrin Lacosamide Rufinamide
mdlinx.com — “New Antiepileptic Drugs: Lacosamide, Rufinamide, and Vigabatrin” View full resource at mdlinx.com
Most Recently Shared on June 2, 2010 at 11:07 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
New Antiepileptic Drugs: Lacosamide, Rufinamide, and Vigabatrin: Current Treatment Options in Ne... http://bit.ly/an0oPO #neurology #mdlinx
Adjunctive rufinamide reduces refractory partial-onset seizures
physorg.com — “Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures (POS). Details of this study are now available online in Epilepsia, a journal published ...” View full resource at physorg.com
Most Recently Shared on October 1, 2010 at 9:51 am By:
PhysOrg Health News Health News
Adjunctive rufinamide reduces refractory partial-onset seizures http://tw.physorg.com/205131053
Study demonstrates rufinamide therapy is effective in reducing partial seizure frequency
news-medical.net — “Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures (POS).” View full resource at news-medical.net
Most Recently Shared on October 1, 2010 at 8:37 am By:
Epilepsy News: Study demonstrates rufinamide therapy is effective in reducing partial seizure frequency: Researche... http://bit.ly/aI5Ipa
Adjunctive rufinamide reduces refractory partial-onset seizures
eurekalert.org — “Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures. Details of this study are now available online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.” View full resource at eurekalert.org
Most Recently Shared on October 1, 2010 at 7:35 am By:
Adjunctive rufinamide reduces refractory partial-onset seizures: ( Wiley-Blackwell ) Researchers from the Arkansas... http://bit.ly/c63jPJ
Adjunctive rufinamide reduces refractory partial-onset seizures
physorg.com — “Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures (POS). Details of this study are now available online in Epilepsia, a journal published ...” View full resource at physorg.com
Most Recently Shared on October 1, 2010 at 1:48 pm By:
Adjunctive rufinamide reduces refractory partial-onset seizures: Researchers from the Arkansas Epilepsy Program fo... http://bit.ly/aaXVzP
Medical News: AAN: Broader Epilepsy Use Touted for Rufinamide - in Meeting Coverage, AAN from MedPage Today
medpagetoday.com — “TORONTO -- Rufinamide (Banzel) was an effective treatment for refractory partial onset seizures in a phase III study, which could bring the drug to a much larger market, it was reported here.” View full resource at medpagetoday.com
Most Recently Shared on April 15, 2010 at 6:37 pm By:
AAN: Broader Epilepsy Use Touted for Rufinamide (CME/CE) TORONTO (MedPage Today) -- Rufinamide (Banzel) was an effectiv.. http://dld.bz/aurW
Medical News: Rufinamide Cuts Partial Seizures - in Neurology, Seizures from MedPage Today
medpagetoday.com — “Adjunctive rufinamide (Banzel) significantly reduced total partial seizures in patients with inadequate response to up to three other antiepileptics, a randomized, placebo-controlled trial showed.” View full resource at medpagetoday.com
Most Recently Shared on October 3, 2010 at 2:37 am By:
Rufinamide Cuts Partial Seizures (CME/CE): (MedPage Today) -- Adjunctive rufinamide (Banzel) significantly reduced... http://bit.ly/d3gTY9
FDA Approves BANZEL(R) (Rufinamide) Oral Suspension, 40 Mg/mL
medicalnewstoday.com — “Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved BANZEL® (rufinamide) Oral Suspension, 40 mg/mL, for the adjunctive treatment of seizures associated wit” View full resource at medicalnewstoday.com
Most Recently Shared on March 7, 2011 at 9:05 am By:
MNT Pediatrics News Pediatrics and Health News
FDA Approves BANZEL(R) (Rufinamide) Oral Suspension, 40 Mg/mL http://mnt.to/3RTV #pediatrics
Rufinamide Cuts Partial Seizures (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Adjunctive rufinamide (Banzel) significantly reduced total partial seizures in patients with inadequate response to up to three other antiepileptics, a randomized, placebo-controlled trial showed.” View full resource at qualitypointtech.net
Most Recently Shared on October 1, 2010 at 9:12 pm By:
Rufinamide Cuts Partial Seizures (CME/CE): (MedPage Today) -- Adjunctive rufinamide (Banzel) significantly reduced... http://bit.ly/bNnZSi
U.S. FDA Approves Anti-Epileptic Agent Banzel® (Rufinamide) Oral Suspension, 40mg/Ml
medicalnewstoday.com — “Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, Eisai) and its U.S. subsidiary Eisai Inc. announced that the United States Food and Drug Administration (FDA) approved the com” View full resource at medicalnewstoday.com
Most Recently Shared on March 5, 2011 at 9:05 am By:
U.S. FDA Approves Anti-Epileptic Agent Banzel® (Rufinamide) Oral Suspension, 40mg/Ml http://mnt.to/3RW7 #epilepsy
U.S. FDA Approves Anti-Epileptic Agent Banzel® (Rufinamide) Oral Suspension, 40mg/Ml
medicalnewstoday.com — “Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, Eisai) and its U.S. subsidiary Eisai Inc. announced that the United States Food and Drug Administration (FDA) approved the com” View full resource at medicalnewstoday.com
Most Recently Shared on March 5, 2011 at 8:57 pm By:
U.S. FDA Approves Anti-Epileptic Agent Banzel® (Rufinamide) Oral Suspension, 40mg/Ml: Eisai Co., Ltd. (Headquar... http://bit.ly/hWymAh
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Epilepsy OW
Organizing epilepsy resources shared by health experts, advocates, and organizations into WisdomCards.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
MNT Epilepsy News
The latest epilepsy news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
